Adult Giant Cell Glioblastoma Completed Phase 3 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0028733 (Adult Giant Cell Glioblastoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00884741Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed GlioblastomaTreatment